Loading…
Structural Determinants of 4-Chloro-m-cresol Required for Activation of Ryanodine Receptor Type 1
4-Chloro-m-cresol (4-CmC) is a clinically relevant activator of the intracellular Ca2+ release channel, the ryanodine receptor isoform 1 (RyR1). In this study, the chemical moieties on the 4-CmC molecule required for its activation of RyR1 were determined using structure-activity relationship analys...
Saved in:
Published in: | Molecular pharmacology 2006-07, Vol.70 (1), p.259-266 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c403t-ef2bd4ddcbd5cd20ac9b63a82fee5b463f3bd682b3774db46860188220f8c8063 |
---|---|
cites | cdi_FETCH-LOGICAL-c403t-ef2bd4ddcbd5cd20ac9b63a82fee5b463f3bd682b3774db46860188220f8c8063 |
container_end_page | 266 |
container_issue | 1 |
container_start_page | 259 |
container_title | Molecular pharmacology |
container_volume | 70 |
creator | Jacobson, Alan R. Moe, Scott T. Allen, P.D. Fessenden, James D. |
description | 4-Chloro-m-cresol (4-CmC) is a clinically relevant activator of the intracellular Ca2+ release channel, the ryanodine receptor isoform 1 (RyR1). In this study, the chemical moieties on the 4-CmC molecule required for its activation of RyR1 were determined using structure-activity relationship analysis with a set of commercially available 4-CmC analogs. Separate compounds each lacking one of the three functional groups of 4-CmC (1-hydroxyl, 3-methyl, or 4-chloro) were poor activators of RyR1. Substitution of different chemical groups for the 1-hydroxyl of 4-CmC resulted in compounds that were poor activators of RyR1, suggesting that the hydroxyl group is preferred at this position. Substitution of hydrophobic groups at the 3-position enhanced bioactivity of the compound relative to 4-CmC, whereas substitution with hydrophilic groups abolished bioactivity. Likewise, 4-CmC analogs with hydrophobic groups substituted into the 4-position enhanced bioactivity, whereas hydrophilic or charged groups diminished bioactivity. 4-CmC analogs containing a single hydrophobic group at either the 3- or 4-position as well as 3,5-disubstituted or 3,4,5-trisubstituted phenols were also effective activators of RyR1. These results indicate that the 1-hydroxyl group of 4-CmC is required for activation of RyR1 and that hydrophobic groups at the 3,4- and 5-positions are preferred. These findings suggest that the 4-CmC binding site on RyR1 most likely consists of a hydrophilic region to interact with the 1-hydroxyl as well as a hydrophobic region(s) to interact with chemical groups at the 3- and/or 4-positions of 4-CmC. |
doi_str_mv | 10.1124/mol.106.022491 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68106344</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0026895X24040549</els_id><sourcerecordid>68106344</sourcerecordid><originalsourceid>FETCH-LOGICAL-c403t-ef2bd4ddcbd5cd20ac9b63a82fee5b463f3bd682b3774db46860188220f8c8063</originalsourceid><addsrcrecordid>eNqF0M1r2zAYwGFRVtqs7XXH4ct6c6Yvy8oxZOs2KBT6Ab0JWXrdaNiWI8kZ-e-n4MBOoycJ8ehF-iH0ieAlIZR_7X23JFgsMaV8Rc7QglSUlJgQ8gEtMKailKvq9RJ9jPE3xoRXEl-gSyIEJliyBdJPKUwmTUF3xTdIEHo36CHFwrcFLzfbzgdf9qUJEH1XPMJucgFs0fpQrE1ye52cH4748aAHb90AGRkYUwbPhxEKco3OW91FuDmtV-jl7vvz5md5__Dj12Z9XxqOWSqhpY3l1prGVsZSrM2qEUxL2gJUDResZY0VkjasrrnNBzJ_QUpKcSuNxIJdodt57hj8boKYVO-iga7TA_gpKiFzJ8b5u5DUtKoEqzNcztAEH2OAVo3B9TocFMHqWF_l-nkv1Fw_X_h8mjw1Pdh__JQ7gy8z2Lq37Z9cUo1bHXptfOffDqrOYxWtVtnJ2UEOtncQVDQOBgM23zFJWe_-94a_r5WgrQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17255637</pqid></control><display><type>article</type><title>Structural Determinants of 4-Chloro-m-cresol Required for Activation of Ryanodine Receptor Type 1</title><source>Free Full-Text Journals in Chemistry</source><creator>Jacobson, Alan R. ; Moe, Scott T. ; Allen, P.D. ; Fessenden, James D.</creator><creatorcontrib>Jacobson, Alan R. ; Moe, Scott T. ; Allen, P.D. ; Fessenden, James D.</creatorcontrib><description>4-Chloro-m-cresol (4-CmC) is a clinically relevant activator of the intracellular Ca2+ release channel, the ryanodine receptor isoform 1 (RyR1). In this study, the chemical moieties on the 4-CmC molecule required for its activation of RyR1 were determined using structure-activity relationship analysis with a set of commercially available 4-CmC analogs. Separate compounds each lacking one of the three functional groups of 4-CmC (1-hydroxyl, 3-methyl, or 4-chloro) were poor activators of RyR1. Substitution of different chemical groups for the 1-hydroxyl of 4-CmC resulted in compounds that were poor activators of RyR1, suggesting that the hydroxyl group is preferred at this position. Substitution of hydrophobic groups at the 3-position enhanced bioactivity of the compound relative to 4-CmC, whereas substitution with hydrophilic groups abolished bioactivity. Likewise, 4-CmC analogs with hydrophobic groups substituted into the 4-position enhanced bioactivity, whereas hydrophilic or charged groups diminished bioactivity. 4-CmC analogs containing a single hydrophobic group at either the 3- or 4-position as well as 3,5-disubstituted or 3,4,5-trisubstituted phenols were also effective activators of RyR1. These results indicate that the 1-hydroxyl group of 4-CmC is required for activation of RyR1 and that hydrophobic groups at the 3,4- and 5-positions are preferred. These findings suggest that the 4-CmC binding site on RyR1 most likely consists of a hydrophilic region to interact with the 1-hydroxyl as well as a hydrophobic region(s) to interact with chemical groups at the 3- and/or 4-positions of 4-CmC.</description><identifier>ISSN: 0026-895X</identifier><identifier>EISSN: 1521-0111</identifier><identifier>DOI: 10.1124/mol.106.022491</identifier><identifier>PMID: 16601083</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Binding Sites ; Binding, Competitive - drug effects ; Cresols - chemistry ; Cresols - metabolism ; Cresols - pharmacology ; Dose-Response Relationship, Drug ; Muscle Fibers, Skeletal - cytology ; Muscle Fibers, Skeletal - drug effects ; Muscle Fibers, Skeletal - metabolism ; Radioligand Assay ; Ryanodine - metabolism ; Ryanodine Receptor Calcium Release Channel - genetics ; Ryanodine Receptor Calcium Release Channel - metabolism ; Structure-Activity Relationship ; Tritium</subject><ispartof>Molecular pharmacology, 2006-07, Vol.70 (1), p.259-266</ispartof><rights>2006 American Society for Pharmacology and Experimental Therapeutics</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c403t-ef2bd4ddcbd5cd20ac9b63a82fee5b463f3bd682b3774db46860188220f8c8063</citedby><cites>FETCH-LOGICAL-c403t-ef2bd4ddcbd5cd20ac9b63a82fee5b463f3bd682b3774db46860188220f8c8063</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16601083$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jacobson, Alan R.</creatorcontrib><creatorcontrib>Moe, Scott T.</creatorcontrib><creatorcontrib>Allen, P.D.</creatorcontrib><creatorcontrib>Fessenden, James D.</creatorcontrib><title>Structural Determinants of 4-Chloro-m-cresol Required for Activation of Ryanodine Receptor Type 1</title><title>Molecular pharmacology</title><addtitle>Mol Pharmacol</addtitle><description>4-Chloro-m-cresol (4-CmC) is a clinically relevant activator of the intracellular Ca2+ release channel, the ryanodine receptor isoform 1 (RyR1). In this study, the chemical moieties on the 4-CmC molecule required for its activation of RyR1 were determined using structure-activity relationship analysis with a set of commercially available 4-CmC analogs. Separate compounds each lacking one of the three functional groups of 4-CmC (1-hydroxyl, 3-methyl, or 4-chloro) were poor activators of RyR1. Substitution of different chemical groups for the 1-hydroxyl of 4-CmC resulted in compounds that were poor activators of RyR1, suggesting that the hydroxyl group is preferred at this position. Substitution of hydrophobic groups at the 3-position enhanced bioactivity of the compound relative to 4-CmC, whereas substitution with hydrophilic groups abolished bioactivity. Likewise, 4-CmC analogs with hydrophobic groups substituted into the 4-position enhanced bioactivity, whereas hydrophilic or charged groups diminished bioactivity. 4-CmC analogs containing a single hydrophobic group at either the 3- or 4-position as well as 3,5-disubstituted or 3,4,5-trisubstituted phenols were also effective activators of RyR1. These results indicate that the 1-hydroxyl group of 4-CmC is required for activation of RyR1 and that hydrophobic groups at the 3,4- and 5-positions are preferred. These findings suggest that the 4-CmC binding site on RyR1 most likely consists of a hydrophilic region to interact with the 1-hydroxyl as well as a hydrophobic region(s) to interact with chemical groups at the 3- and/or 4-positions of 4-CmC.</description><subject>Animals</subject><subject>Binding Sites</subject><subject>Binding, Competitive - drug effects</subject><subject>Cresols - chemistry</subject><subject>Cresols - metabolism</subject><subject>Cresols - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Muscle Fibers, Skeletal - cytology</subject><subject>Muscle Fibers, Skeletal - drug effects</subject><subject>Muscle Fibers, Skeletal - metabolism</subject><subject>Radioligand Assay</subject><subject>Ryanodine - metabolism</subject><subject>Ryanodine Receptor Calcium Release Channel - genetics</subject><subject>Ryanodine Receptor Calcium Release Channel - metabolism</subject><subject>Structure-Activity Relationship</subject><subject>Tritium</subject><issn>0026-895X</issn><issn>1521-0111</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqF0M1r2zAYwGFRVtqs7XXH4ct6c6Yvy8oxZOs2KBT6Ab0JWXrdaNiWI8kZ-e-n4MBOoycJ8ehF-iH0ieAlIZR_7X23JFgsMaV8Rc7QglSUlJgQ8gEtMKailKvq9RJ9jPE3xoRXEl-gSyIEJliyBdJPKUwmTUF3xTdIEHo36CHFwrcFLzfbzgdf9qUJEH1XPMJucgFs0fpQrE1ye52cH4748aAHb90AGRkYUwbPhxEKco3OW91FuDmtV-jl7vvz5md5__Dj12Z9XxqOWSqhpY3l1prGVsZSrM2qEUxL2gJUDResZY0VkjasrrnNBzJ_QUpKcSuNxIJdodt57hj8boKYVO-iga7TA_gpKiFzJ8b5u5DUtKoEqzNcztAEH2OAVo3B9TocFMHqWF_l-nkv1Fw_X_h8mjw1Pdh__JQ7gy8z2Lq37Z9cUo1bHXptfOffDqrOYxWtVtnJ2UEOtncQVDQOBgM23zFJWe_-94a_r5WgrQ</recordid><startdate>20060701</startdate><enddate>20060701</enddate><creator>Jacobson, Alan R.</creator><creator>Moe, Scott T.</creator><creator>Allen, P.D.</creator><creator>Fessenden, James D.</creator><general>Elsevier Inc</general><general>American Society for Pharmacology and Experimental Therapeutics</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7X8</scope></search><sort><creationdate>20060701</creationdate><title>Structural Determinants of 4-Chloro-m-cresol Required for Activation of Ryanodine Receptor Type 1</title><author>Jacobson, Alan R. ; Moe, Scott T. ; Allen, P.D. ; Fessenden, James D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c403t-ef2bd4ddcbd5cd20ac9b63a82fee5b463f3bd682b3774db46860188220f8c8063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Animals</topic><topic>Binding Sites</topic><topic>Binding, Competitive - drug effects</topic><topic>Cresols - chemistry</topic><topic>Cresols - metabolism</topic><topic>Cresols - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Muscle Fibers, Skeletal - cytology</topic><topic>Muscle Fibers, Skeletal - drug effects</topic><topic>Muscle Fibers, Skeletal - metabolism</topic><topic>Radioligand Assay</topic><topic>Ryanodine - metabolism</topic><topic>Ryanodine Receptor Calcium Release Channel - genetics</topic><topic>Ryanodine Receptor Calcium Release Channel - metabolism</topic><topic>Structure-Activity Relationship</topic><topic>Tritium</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jacobson, Alan R.</creatorcontrib><creatorcontrib>Moe, Scott T.</creatorcontrib><creatorcontrib>Allen, P.D.</creatorcontrib><creatorcontrib>Fessenden, James D.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jacobson, Alan R.</au><au>Moe, Scott T.</au><au>Allen, P.D.</au><au>Fessenden, James D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Structural Determinants of 4-Chloro-m-cresol Required for Activation of Ryanodine Receptor Type 1</atitle><jtitle>Molecular pharmacology</jtitle><addtitle>Mol Pharmacol</addtitle><date>2006-07-01</date><risdate>2006</risdate><volume>70</volume><issue>1</issue><spage>259</spage><epage>266</epage><pages>259-266</pages><issn>0026-895X</issn><eissn>1521-0111</eissn><abstract>4-Chloro-m-cresol (4-CmC) is a clinically relevant activator of the intracellular Ca2+ release channel, the ryanodine receptor isoform 1 (RyR1). In this study, the chemical moieties on the 4-CmC molecule required for its activation of RyR1 were determined using structure-activity relationship analysis with a set of commercially available 4-CmC analogs. Separate compounds each lacking one of the three functional groups of 4-CmC (1-hydroxyl, 3-methyl, or 4-chloro) were poor activators of RyR1. Substitution of different chemical groups for the 1-hydroxyl of 4-CmC resulted in compounds that were poor activators of RyR1, suggesting that the hydroxyl group is preferred at this position. Substitution of hydrophobic groups at the 3-position enhanced bioactivity of the compound relative to 4-CmC, whereas substitution with hydrophilic groups abolished bioactivity. Likewise, 4-CmC analogs with hydrophobic groups substituted into the 4-position enhanced bioactivity, whereas hydrophilic or charged groups diminished bioactivity. 4-CmC analogs containing a single hydrophobic group at either the 3- or 4-position as well as 3,5-disubstituted or 3,4,5-trisubstituted phenols were also effective activators of RyR1. These results indicate that the 1-hydroxyl group of 4-CmC is required for activation of RyR1 and that hydrophobic groups at the 3,4- and 5-positions are preferred. These findings suggest that the 4-CmC binding site on RyR1 most likely consists of a hydrophilic region to interact with the 1-hydroxyl as well as a hydrophobic region(s) to interact with chemical groups at the 3- and/or 4-positions of 4-CmC.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>16601083</pmid><doi>10.1124/mol.106.022491</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0026-895X |
ispartof | Molecular pharmacology, 2006-07, Vol.70 (1), p.259-266 |
issn | 0026-895X 1521-0111 |
language | eng |
recordid | cdi_proquest_miscellaneous_68106344 |
source | Free Full-Text Journals in Chemistry |
subjects | Animals Binding Sites Binding, Competitive - drug effects Cresols - chemistry Cresols - metabolism Cresols - pharmacology Dose-Response Relationship, Drug Muscle Fibers, Skeletal - cytology Muscle Fibers, Skeletal - drug effects Muscle Fibers, Skeletal - metabolism Radioligand Assay Ryanodine - metabolism Ryanodine Receptor Calcium Release Channel - genetics Ryanodine Receptor Calcium Release Channel - metabolism Structure-Activity Relationship Tritium |
title | Structural Determinants of 4-Chloro-m-cresol Required for Activation of Ryanodine Receptor Type 1 |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T06%3A57%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Structural%20Determinants%20of%204-Chloro-m-cresol%20Required%20for%20Activation%20of%20Ryanodine%20Receptor%20Type%201&rft.jtitle=Molecular%20pharmacology&rft.au=Jacobson,%20Alan%20R.&rft.date=2006-07-01&rft.volume=70&rft.issue=1&rft.spage=259&rft.epage=266&rft.pages=259-266&rft.issn=0026-895X&rft.eissn=1521-0111&rft_id=info:doi/10.1124/mol.106.022491&rft_dat=%3Cproquest_cross%3E68106344%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c403t-ef2bd4ddcbd5cd20ac9b63a82fee5b463f3bd682b3774db46860188220f8c8063%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17255637&rft_id=info:pmid/16601083&rfr_iscdi=true |